These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 32365886)

  • 1. Functionalized Carbon Nanostructures Versus Drug Resistance: Promising Scenarios in Cancer Treatment.
    Curcio M; Farfalla A; Saletta F; Valli E; Pantuso E; Nicoletta FP; Iemma F; Vittorio O; Cirillo G
    Molecules; 2020 Apr; 25(9):. PubMed ID: 32365886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid-functionalized dextran nanosystems to overcome multidrug resistance in cancer: a pilot study.
    Kobayashi E; Iyer AK; Hornicek FJ; Amiji MM; Duan Z
    Clin Orthop Relat Res; 2013 Mar; 471(3):915-25. PubMed ID: 23011844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overcoming Drug Resistance in Colon Cancer by Aptamer-Mediated Targeted Co-Delivery of Drug and siRNA Using Grapefruit-Derived Nanovectors.
    Yan W; Tao M; Jiang B; Yao M; Jun Y; Dai W; Tang Z; Gao Y; Zhang L; Chen X; Wang QL
    Cell Physiol Biochem; 2018; 50(1):79-91. PubMed ID: 30278432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new insight into the reversal of multidrug resistance in cancer by nanodrugs.
    Jiang H; Guo D; Chen D; Wu Y; Jin X; Zhu X
    Biomater Sci; 2019 Aug; 7(8):3489-3496. PubMed ID: 31282916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversion of multidrug resistance in tumor by biocompatible nanomaterials.
    Zhang H; Jiang H; Wang X; Chen B
    Mini Rev Med Chem; 2010 Jul; 10(8):737-45. PubMed ID: 20565385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors.
    Dallavalle S; Dobričić V; Lazzarato L; Gazzano E; Machuqueiro M; Pajeva I; Tsakovska I; Zidar N; Fruttero R
    Drug Resist Updat; 2020 May; 50():100682. PubMed ID: 32087558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene/drug-embedded nanoscale metal azolate framework-7 for the reversal of P-glycoprotein-mediated multidrug resistance.
    Li X; He Y; Yang L; He Z; Zhu JJ
    Chem Commun (Camb); 2021 Jul; 57(55):6776-6779. PubMed ID: 34137399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of integrated cancer nanomedicine in overcoming drug resistance.
    Iyer AK; Singh A; Ganta S; Amiji MM
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2.
    Dai CL; Tiwari AK; Wu CP; Su XD; Wang SR; Liu DG; Ashby CR; Huang Y; Robey RW; Liang YJ; Chen LM; Shi CJ; Ambudkar SV; Chen ZS; Fu LW
    Cancer Res; 2008 Oct; 68(19):7905-14. PubMed ID: 18829547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological strategies for overcoming multidrug resistance.
    Nobili S; Landini I; Giglioni B; Mini E
    Curr Drug Targets; 2006 Jul; 7(7):861-79. PubMed ID: 16842217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-modal strategies for overcoming tumor drug resistance: hypoxia, the Warburg effect, stem cells, and multifunctional nanotechnology.
    Milane L; Ganesh S; Shah S; Duan ZF; Amiji M
    J Control Release; 2011 Oct; 155(2):237-47. PubMed ID: 21497176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidrug resistance: genes, polymorphisms, biologic effects, reversal and treatment in cancer chemotherapy.
    Aragon-Ching JB
    Anticancer Agents Med Chem; 2010 Oct; 10(8):582. PubMed ID: 21244347
    [No Abstract]   [Full Text] [Related]  

  • 13. Carbon nanotubes for delivery of small molecule drugs.
    Wong BS; Yoong SL; Jagusiak A; Panczyk T; Ho HK; Ang WH; Pastorin G
    Adv Drug Deliv Rev; 2013 Dec; 65(15):1964-2015. PubMed ID: 23954402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. β-Casein micelles for oral delivery of SN-38 and elacridar to overcome BCRP-mediated multidrug resistance in gastric cancer.
    Bar-Zeev M; Kelmansky D; Assaraf YG; Livney YD
    Eur J Pharm Biopharm; 2018 Dec; 133():240-249. PubMed ID: 30367935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effect of Nanosystems on ATP-Binding Cassette Transporters: Understanding the Influence of Nanosystems on Multidrug Resistance Protein-1 and P-glycoprotein.
    Mello FVC; de Moraes GN; Maia RC; Kyeremateng J; Iram SH; Santos-Oliveira R
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32290047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of P-glycoprotein in drug resistance in multiple myeloma.
    Abraham J; Salama NN; Azab AK
    Leuk Lymphoma; 2015 Jan; 56(1):26-33. PubMed ID: 24678978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nano revolution of DNA nanostructures redefining cancer therapeutics-A comprehensive review.
    Yadav K; Gnanakani SPE; Sahu KK; Veni Chikkula CK; Vaddi PS; Srilakshmi S; Yadav R; Sucheta ; Dubey A; Minz S; Pradhan M
    Int J Biol Macromol; 2024 Aug; 274(Pt 1):133244. PubMed ID: 38901506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanomaterial-induced autophagy: a new reversal MDR tool in cancer therapy?
    Panzarini E; Dini L
    Mol Pharm; 2014 Aug; 11(8):2527-38. PubMed ID: 24921216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversing agents for ATP-binding cassette (ABC) transporters: application in modulating multidrug resistance (MDR).
    Lee CH
    Curr Med Chem Anticancer Agents; 2004 Jan; 4(1):43-52. PubMed ID: 14754411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. When polymers meet carbon nanostructures: expanding horizons in cancer therapy.
    Cirillo G; Peitzsch C; Vittorio O; Curcio M; Farfalla A; Voli F; Dubrovska A; Iemma F; Kavallaris M; Hampel S
    Future Med Chem; 2019 Aug; 11(16):2205-2231. PubMed ID: 31538523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.